moonshot
93.353
To provide support for initiatives funded under the 21st Century Cures Act to support cancer research, such as the development of cancer vaccines, the development of more sensitive diagnostic tests for cancer, immunotherapy and the development of combination therapies, and research that has the potential to transform the scientific field, that has inherently higher risk, and that seeks to address major challenges related to cancer.
This chart shows obligations for the program by fiscal year. All data for this chart was provided by the
administering agency and sourced from SAM.gov, USASpending.gov, and Treasury.gov.
For more information on each of these data sources, please see the
About the data page.
FY2017 actual total awards to be made is 48.
FY2018 actual total awards to be made is 28.
FY2019 actual total awards made is 18.
FY2020 actual awards made was 21.
FY2021 total awards made was 9.
FY2022 actual awards made were 16.
FY2023 actual awards made were 19.
FY2024 estimated total awards to be made is 0.
FY2025 estimated total awards to be made is 435.
Single Audit Applies (2 CFR Part 200 Subpart F):
For additional information on single audit requirements for this program, review the current Compliance Supplement.
OMB is working with the U.S. Government Accountability Office (GAO) and agency offices of inspectors general to include links to relevant oversight reports. This section will be updated once this information is made available.